MENU
+Compare
KNSA
Stock ticker: NASDAQ
AS OF
Sep 3, 04:59 PM (EDT)
Price
$35.50
Change
+$1.22 (+3.56%)
Capitalization
2.54B

KNSA Kiniksa Pharmaceuticals International plc Forecast, Technical & Fundamental Analysis

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for KNSA with price predictions
Sep 02, 2025

KNSA in upward trend: 10-day moving average crossed above 50-day moving average on July 30, 2025

The 10-day moving average for KNSA crossed bullishly above the 50-day moving average on July 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 29, 2025. You may want to consider a long position or call options on KNSA as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

KNSA moved above its 50-day moving average on July 29, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KNSA advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where KNSA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KNSA moved out of overbought territory on August 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where KNSA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KNSA turned negative on August 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KNSA broke above its upper Bollinger Band on September 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KNSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.131) is normal, around the industry mean (16.002). KNSA's P/E Ratio (685.600) is considerably higher than the industry average of (73.939). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.012). KNSA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (4.826) is also within normal values, averaging (41.991).

View a ticker or compare two or three
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

KNSA is expected to report earnings to rise 36.48% to 31 cents per share on November 04

Kiniksa Pharmaceuticals International plc KNSA Stock Earnings Reports
Q3'25
Est.
$0.31
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.14
Q3'24
Missed
by $0.19
The last earnings report on July 29 showed earnings per share of 23 cents, beating the estimate of 18 cents. With 289.05K shares outstanding, the current market capitalization sits at 2.54B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLNCX25.65N/A
N/A
Morgan Stanley Instl Glbl Concntr C
LSPAX5.48-0.03
-0.54%
LoCorr Spectrum Income A
NDVSX17.71-0.10
-0.56%
MFS New Discovery Value R2
IRLUX45.59-0.30
-0.65%
Voya Russell Large Cap Index Port S2
MINIX47.51-0.38
-0.79%
MFS International Intrinsic Value I

KNSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+2.36%
COYA - KNSA
39%
Loosely correlated
-0.61%
JBIO - KNSA
37%
Loosely correlated
-3.54%
SNDX - KNSA
36%
Loosely correlated
-1.29%
CPRX - KNSA
35%
Loosely correlated
-0.24%
ATXS - KNSA
35%
Loosely correlated
+6.63%
More

Groups containing KNSA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+2.36%
Pharmaceuticals: Generic
industry (224 stocks)
13%
Poorly correlated
-0.09%